-relix
A non-peptide GnRH antagonist; used in prostate cancer and endometriosis.
- Drugs ending in -relix: 6
- Approved somewhere: 4
- With a US drug page: 4
- Stem
- -relix
- Class
- Drugs that block the GnRH receptor
- Most common targets
- GNRHR (5)
Approved and clinical-stage drugs in ChEMBL whose names ending in -relix, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Abarelix | Approved | GNRHR | Gonadotropin-releasing hormone receptor antagonist |
| Cetrorelix | Approved | GNRHR | Gonadotropin-releasing hormone receptor antagonist |
| Degarelix | Approved | GNRHR | Gonadotropin-releasing hormone receptor antagonist |
| Ganirelix | Approved | GNRHR | Gonadotropin-releasing hormone receptor antagonist |
| Ozarelix | Phase 2 | GNRHR | Gonadotropin-releasing hormone receptor antagonist |
| Teverelix | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO